Tenet Healthcare Corporation (NYSE:THC)‘s stock had its “neutral” rating reiterated by investment analysts at Mizuho in a research note issued on Sunday. They currently have a $14.00 price objective on the stock. Mizuho’s price objective suggests a potential downside of 3.11% from the company’s previous close.

A number of other research analysts have also issued reports on THC. Citigroup Inc. restated a “neutral” rating and set a $16.00 target price (down previously from $20.00) on shares of Tenet Healthcare Corporation in a research report on Thursday, August 10th. Deutsche Bank AG restated a “buy” rating and set a $24.00 target price (down previously from $28.00) on shares of Tenet Healthcare Corporation in a research report on Thursday, August 10th. Leerink Swann restated an “outperform” rating and set a $23.00 target price (down previously from $27.00) on shares of Tenet Healthcare Corporation in a research report on Sunday. Robert W. Baird restated an “outperform” rating and set a $23.00 target price on shares of Tenet Healthcare Corporation in a research report on Thursday, August 10th. Finally, Jefferies Group LLC restated a “buy” rating and set a $24.00 target price (down previously from $26.00) on shares of Tenet Healthcare Corporation in a research report on Tuesday, August 8th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $20.93.

Tenet Healthcare Corporation (NYSE THC) traded up 14.23% during midday trading on Friday, reaching $14.45. The company had a trading volume of 12,079,290 shares. Tenet Healthcare Corporation has a one year low of $12.54 and a one year high of $24.96. The firm’s market capitalization is $1.46 billion. The stock’s 50 day moving average price is $17.36 and its 200-day moving average price is $17.86.

Tenet Healthcare Corporation (NYSE:THC) last announced its earnings results on Monday, August 7th. The company reported ($0.17) earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of ($0.17). Tenet Healthcare Corporation had a negative net margin of 0.97% and a negative return on equity of 2.00%. The firm had revenue of $14.80 billion for the quarter, compared to analyst estimates of $4.90 billion. During the same quarter in the prior year, the business posted $0.38 EPS. The business’s revenue was up 204.1% compared to the same quarter last year. On average, equities research analysts anticipate that Tenet Healthcare Corporation will post $0.82 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This article was first published by American Banking News and is owned by of American Banking News. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/08/20/tenet-healthcare-corporation-thc-given-neutral-rating-at-mizuho.html.

Institutional investors have recently modified their holdings of the stock. Glenview Capital Management LLC bought a new position in shares of Tenet Healthcare Corporation during the fourth quarter valued at approximately $265,491,000. BlackRock Advisors LLC increased its position in shares of Tenet Healthcare Corporation by 86.2% in the third quarter. BlackRock Advisors LLC now owns 4,567,713 shares of the company’s stock valued at $103,504,000 after buying an additional 2,114,791 shares during the last quarter. North Tide Capital LLC bought a new position in shares of Tenet Healthcare Corporation during the first quarter valued at approximately $35,420,000. Orbimed Advisors LLC increased its position in shares of Tenet Healthcare Corporation by 86.5% in the fourth quarter. Orbimed Advisors LLC now owns 3,716,700 shares of the company’s stock valued at $55,156,000 after buying an additional 1,723,700 shares during the last quarter. Finally, Harris Associates L P increased its position in shares of Tenet Healthcare Corporation by 25.6% in the fourth quarter. Harris Associates L P now owns 8,346,668 shares of the company’s stock valued at $252,904,000 after buying an additional 1,701,615 shares during the last quarter.

About Tenet Healthcare Corporation

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Analyst Recommendations for Tenet Healthcare Corporation (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.